Antibiotic Therapy: The Cornerstone of Iatrogenic Resistance to Immune Checkpoint Inhibitors

J Clin Oncol. 2023 Jun 10;41(17):3089-3091. doi: 10.1200/JCO.23.00049. Epub 2023 Feb 24.

Authors

David J Pinato^{1

2}, Alessio Cortellini^{1

3}

Affiliations

¹ Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, Hammersmith Hospital, London, United Kingdom.
² Division of Oncology, Department of Translational Medicine, University of Piemonte Orientale, Novara, Italy.
³ Medical Oncology, Fondazione Policlinico Universitario Campus BioMedico, Rome, Italy.

PMID: 36827618
DOI: 10.1200/JCO.23.00049

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anti-Bacterial Agents / adverse effects
Drug Resistance, Neoplasm*
Humans
Iatrogenic Disease
Immune Checkpoint Inhibitors*
Immunotherapy

Substances

Immune Checkpoint Inhibitors
Anti-Bacterial Agents